
Sign up to save your podcasts
Or


When can I play again after tearing my ACL? Joshua Reside, MD, Orthopaedic Surgeon at UF Health Shands Hospital, explains what "return to play" really means and the three phases—participation, competition, and performance. He covers reconstruction options (autograft quadriceps or patellar tendon), typical timelines, the role of physical therapy, and objective testing such as Biodex strength comparisons and limb symmetry before returning to sport.
Learn more about Joshua Reside, MD
Worried about what happens after a pregnancy loss? Mehmet R Genc, MD, Ph.D., Medical director for Butterfly Program, Professor, Department of Obstetrics and Gynecology, UF Shands, University of Florida College of Medicine, explains the Butterfly Program’s approach. Learn how the team combines medical evaluation, grief and psychosocial support, and future-pregnancy planning. Topics include timing of follow-up, placenta histopathology and genetic testing, how results are explained, and what “closure” and recurrence-risk counseling may look like.
Learn more about Dr. Genc
Worried about sudden chest or back pain, known aneurysm, or a family history of aortic disease? Eric Jeng, MD, MBA, FACS, FACS, FACC, FCCP, Director of the UF Health Aortic Disease Center and Associate Professor, Division of Cardiovascular Surgery, University of Florida, walks through recognizing classic and atypical presentations, the difference between Stanford A (requires urgent open repair) and Stanford B (often managed with heart-rate and blood-pressure control unless malperfusion occurs), and modern treatment options including endovascular stents, hybrid repairs, and advanced arch techniques. He discusses prevention strategies — genetic testing and family screening, size-based timing for prophylactic surgery in connective tissue disorders versus the general population — and how multidisciplinary aortic centers, clinical pathways, and emerging AI prediction tools are shaping individualized care and better outcomes.
This episode features a discussion with Martin Back, MD, Professor of Surgery and Chief of the Division of Vascular Surgery and Endovascular Therapy at the University of Florida College of Medicine and Dr. Eric Jeng, Associate Professor of Cardiovascular Surgery at the University of Florida College of Medicine and Director of the UF Health Aortic Disease Center. Dr. Jeng is also the Surgical Director of the Mechanical Circulatory Support Program and the Bicuspid Aortic Valve Program.
Dr. Back specializes in complex vascular disease and aortic intervention, with a particular interest in the anatomy and treatment of challenging aortic conditions. Dr. Jeng’s clinical expertise includes complex aortic and valve surgery, heart transplantation, mechanical circulatory support, minimally invasive cardiac surgery and transcatheter valve
procedures.
Join us as we explore open and endovascular options for aortic surgery and how surgeons approach treatment when standard endovascular access or repair is not possible. The discussion highlights how careful understanding of anatomy, surgical planning and long-term follow-up can help guide treatment decisions for patients with complex aortic disease.
What treatment options exist for progressive interstitial lung disease and pulmonary hypertension‑ILD? Jared Freitas, M.D., an assistant professor in the Division of Pulmonary, Critical Care & Sleep Medicine in the University of Florida College of Medicine's Department of Medicine, explains current therapies. He reviews anti‑fibrotic drugs (nintedanib/Ofev, pirfenidone/Esbriet), the newer PDE4B inhibitor nirandromolast (JAZZCAID) and inhaled treprostinil (Tyvaso) for PH‑ILD, plus when immunosuppression, combination therapy, and close monitoring are considered.
"Should I refer now or wait until it's the last resort?" Moustafa Younis, MD, MSCR, Assistant Professor of Medicine, Division of Pulmonary, Critical Care and Sleep Medicine at UF Health Shands Hospital, explains when to start transplant conversations. Learn why early referral preserves options, the two-year ~50% mortality threshold despite optimal therapy, and common referral triggers: oxygen requirement, pulmonary hypertension, hypercapnia, frequent hospitalizations, and declining exercise capacity. He also outlines the evaluation outcomes and modifiable barriers that affect listing.
This episode explores the tension between getting players back on the court and protecting their long-term health—and why that balance matters. Dr. Ryan Roach, MD, orthopedic surgeon and team physician for the University of Florida Gators basketball team, describes how he weighs surgical options, rehab commitment, and season timing when making return-to-play decisions. Hear real examples of common basketball injuries and how a team-based sports medicine approach informs care. Keywords: return-to-play decisions, sports medicine, orthopedic surgery, Achilles tendon injury, rehabilitation, collegiate sports. For more, visit innovation.ufhealth.org.
#TeamPhysician
#SportsMedicine
#Orthopaedics
#ReturnToPlay
#CollegiateAthletics
#InjuryPrevention
In this episode, Dr. Hoh describes the UF Health Comprehensive Spine Center– a multidisciplinary team of spine physicians and surgeons providing a patient-centered approach to enhance outcomes through medical, interventional and surgical (complex and minimally invasive) treatment.
Learn more about Daniel J. Hoh, MD, MBA
This episode explains how clinicians distinguish overactive bladder from other lower urinary tract disorders and why an accurate history matters for diagnosis and treatment. Dr. Alex Gomelsky, MD, clinical urologist with UF Health and professor at the University of Florida College of Medicine, walks through the defining symptoms of urgency, urinary frequency, and urge leakage and how these differ from stress incontinence or pelvic organ prolapse. Learn practical tips for history-taking, the role of pelvic floor physical therapy, and when to consider bladder medications versus procedural options such as Botox for bladder or sacral neuromodulation. Visit ufhealth.org/urogynecology to learn more and access resources for patients and clinicians.
Learn more about Dr. Alex Gomelsky MD, FACS
In this episode, Drs. Busl and Maciel will describe their programmatic approach to building a neurocritical care research program that is multifaceted and includes a national multicenter, investigator-initiated clinical trial, BLOCK-SAH. They will also talk about the power of team science and shared leadership at UF Neurocritical Care, with the goal to propel neurocritical care research while fostering a new generation of clinical scientists.
Learn more about Carolina B. Maciel, MD, MSCR
Learn more about Katharina M. Busl, MD, MS
From the publisher's feed

1,306 Listeners

58 Listeners

40 Listeners

5 Listeners